Position in PTCT
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$615,200
+$399,024 QoQ
Shares Held
7,542
+137.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#210
of 380 holders
Holding Since
Dec 2025
3 quarters on record
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Summit Global Investments holds $20,708,446 across 14 Biotechnology names. PTCT ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
55,370 | $6,276,743 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,506 | $4,680,291 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,182 | $3,567,514 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
32,667 | $1,869,205 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
27,034 | $984,307 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
2,167 | $805,408 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
This page
|
7,542 | $615,200 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,937 | $612,266 |
All Filings in PTCT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $615,200 | 7,542 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $216,176 | 3,173 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $242,008 | 3,186 | Shares | Sole | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||